40
Participants
Start Date
August 1, 2025
Primary Completion Date
July 1, 2027
Study Completion Date
July 1, 2028
Carboplatin and a Taxane
"All patients will receive Carboplatin and a Taxane for 4 cycles.~* Patients who achieve a complete radiological response will proceed directly to surgery.~* Patients without a complete radiological response will receive Doxorubicin and Cyclophosphamide, with or without Pembrolizumab, for an additional 4 cycles before surgery."
Instituto D'Or de Pesquisa e Ensino de Brasília, Brasília
Instituto D'Or de Pesquisa e Ensino de Curitiba, Curitiba
Instituto D'Or de Pesquisa e Ensino do Rio de Janeiro, Rio de Janeiro
Instituto D'Or de Pesquisa e Ensino de Salvador, Salvador
Instituto D'Or de Pesquisa e Ensino de São Paulo, São Paulo
Grupo Brasileiro de Estudos do Câncer de Mama (GBECAM)
UNKNOWN
D'Or Institute for Research and Education
OTHER